Latest Press Releases

New Data from Largest Prospective Study on CroFab® for Treatment of Copperhead Snake Envenomation 4/25/2016 7:00:10 AM

BTG plc (LSE: BTG) announced today the presentation of new data from the largest prospective study ever conducted in the treatment of copperhead snake envenomation. This study builds on the extensive body of evidence supporting the safety and efficacy of CroFab® Crotalidae Polyvalent Immune Fab (Ovine) in treating copperhead snake envenomation. The data were shared in a keynote presentation at the Venom Week V International Scientific Symposium (March 9-12) in Greenville, NC.